Hantavirus: Have We Learned Nothing?
The headlines are starting again.
Cruise ships. Emergency evacuations. Contact tracing. International alerts…
Before most Canadians even know what hantavirus is, the media has already begun flooding the public with emotionally charged coverage designed to trigger fear and urgency.
For many, the pattern feels painfully familiar.
2020: COVID
2022: Monkeypox
2024: Bird Flu
2026: Hantavirus
According to Dr. Sherri Tenpenny, the issue is not whether hantavirus exists, but whether the public is receiving balanced risk information — or being pushed once again into a cycle of fear-driven compliance.
What Is Hantavirus?
Hantaviruses are a family of RNA viruses typically associated with rodents, particularly deer mice. Infection is considered rare and is generally linked to exposure to aerosolized rodent urine, saliva or droppings.
The virus gained public attention in 1993 during the Four Corners outbreak in the southwestern United States, where investigators identified what later became known as Sin Nombre virus.
According to the CDC, approximately 890 confirmed hantavirus cases were reported in the United States between 1993 and 2023 — averaging roughly 10 deaths annually.
The overwhelming scientific understanding of hantavirus has historically centered on environmental exposure, not widespread community transmission.
That distinction matters.
Fear First, Context Later
The concern raised by Dr. Tenpenny is not simply about hantavirus itself, but about the familiar public health and media response surrounding emerging pathogens.
COVID normalized unprecedented levels of fear-based messaging, emergency powers, surveillance infrastructure, censorship and rapid pharmaceutical rollout. Critics of those policies warn that similar tactics are now being reintroduced through each new viral scare cycle.
Cruise ships, quarantines, contact tracing and isolation protocols are not neutral imagery. They evoke powerful memories from the COVID era and can quickly trigger public fear responses before critical questions are asked.
Hantavirus “Vaccines” Already in Development
Nicolas Hulscher reported that there are 13 documented hantavirus vaccine and gene therapy platforms in active development.
These reportedly include:
- 6 DNA “vaccines” (US Army / USAMRIID) — many of them “needle-free” jet-injector versions
- 3 mRNA “vaccines” (Moderna + Korea University, Chinese research team, VIDO Canada)
- 2 viral vector “vaccines” (UK institutions + VIDO Canada)
- 1 inactivated vaccine (Hantavax — already licensed and used in South Korea)
- 1 protein subunit vaccine (VIDO Canada)
The rapid existence of pharmaceutical platforms for a relatively rare disease raises questions many Canadians are now asking:
Why does public health messaging so often move quickly toward injections instead of focusing first on environmental mitigation, rodent control and targeted risk awareness?
Observation — Not Hysteria
Hantavirus warrants awareness and reasonable precaution. It does not warrant panic.
If the COVID years taught Canadians anything, it is that fear and urgency can be used to push populations past scrutiny and critical thinking.
As new disease narratives emerge, Canadians should remain informed, ask difficult questions and resist emotionally driven compliance rooted in fear rather than evidence.
Sources:
Dr. Tenpenny’s Eye on the Evidence Substack — Hantavirus: Have We Learned Nothing?
FOCAL POINTS (Courageous Discourse) Substack — The Vaccine Cartel and US Army Are Developing 13 Hantavirus Vaccines and Gene Therapies
WATCH: CHD’s Director of Science and Research, Karl Jablonowski, Ph.D. on CHD-TV:
The Hantavirus Panic Machine: When Rare Diseases Become Media Theater
********************************************************************************************************